Boston Scientific BSX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net sales of reportable segments by Business | ||||||
| Cardiovascular | $3.5B+10.9% | $3.47B+16.4% | $3.33B+21.4% | $3.34B+25.4% | $3.16B+28.4% | |
| MedSurg | $1.7B+5.7% | $1.8B+10.1% | $1.71B+15.5% | $1.71B+14.6% | $1.61B+13.5% | |
| Net Sales by Product | ||||||
| Cardiac Rhythm Management | $578M0.0% | $586M+3.5% | $578M+3.0% | $590M+2.4% | $578M+0.5% | |
| Electrophysiology | $905M+24.0% | $890M+37.1% | $865M+64.1% | $840M+96.3% | $730M+143% | |
| Endoscopy | $736M+9.4% | $759M+9.8% | $747M+10.2% | $737M+9.0% | $673M+4.8% | |
| Interventional Cardiology & Vascular Therapies | $1.24B+10.7% | —— | $686M+3.8% | $731M+9.9% | $1.12B+72.4% | |
| Interventional Oncology & Embolization | $268M+17.5% | —— | —— | —— | $228M+6.5% | |
| Neuromodulation | $318M+17.3% | $333M+11.4% | $293M+9.3% | $303M+7.4% | $271M+5.9% | |
| Urology | $646M+2.1% | $717M+13.8% | $682M+28.2% | $676M+28.8% | $633M+23.4% | |
| Watchman | $506M+19.1% | $535M+29.5% | $512M+34.7% | $486M+28.2% | $425M+23.5% | |
| Net Sales by Geography | ||||||
| Asia-Pacific | $803M+14.6% | $788M+15.2% | $802M+17.3% | $790M+17.9% | $701M+8.3% | |
| Europe, Middle East and Africa | $932M+10.2% | $933M+12.4% | $793M+2.6% | $878M+6.8% | $846M+5.4% | |
| Latin America and Canada | $185M+19.4% | $179M+15.5% | $175M+10.1% | $169M+4.3% | $155M+4.0% | |
| U.S. | $3.28B+10.9% | $3.39B+17.0% | $3.29B+27.0% | $3.22B+30.7% | $2.96B+31.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Boston Scientific break its business down?
- Boston Scientific (BSX) reports net sales of reportable segments by business across 2 parts — Cardiovascular and MedSurg. Each is extracted from the segment footnotes and tracked over time.
- Where does Boston Scientific's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Boston Scientific's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
